3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
暂无分享,去创建一个
Ulas Bagci | Jesus Velasco | Joshua C. Johnson | Daniel J Mollura | Jeffrey Solomon | Michael R Holbrook | Lisa E Hensley | Peter B Jahrling | Jing Qin | D. Mollura | U. Bagci | R. Baric | J. Qin | O. Bohorov | N. Bohorova | C. Goodman | J. Velasco | James Pettitt | G. Olinger | K. Whaley | L. Zeitlin | P. Jahrling | W. Marasco | L. Hensley | Xian-Chun Tang | Reed F. Johnson | J. Solomon | Wayne A Marasco | Jiusong Sun | Ralph S Baric | Larry Zeitlin | Q. Zhu | Quan Zhu | James Pettitt | L. Huzella | M. Holbrook | Ognian Bohorov | Jiusong Sun | Kevin J Whaley | Natasha Bohorova | Charles Goodman | Gene G Olinger | Reed F Johnson | Lauren Keith | Xianchun Tang | Louis Huzella | Christopher J Bartos | Do H Kim | Michael H Paulty | Joshua C Johnson | Britini L Ork | Nicholas Oberlander | Lauren Keith | Christopher Bartos | Do H. Kim | Nicholas Oberlander | J. Pettitt | Louis Huzella | Ulas Bagci | Charles Goodman | Jesus Velasco | Britini L. Ork
[1] Joshua C. Johnson,et al. Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease , 2015, Virology.
[2] Ulas Bagci,et al. Evaluation of candidate vaccine approaches for MERS-CoV , 2015, Nature Communications.
[3] Xiaoyan Lu,et al. MERS-CoV in Upper Respiratory Tract and Lungs of Dromedary Camels, Saudi Arabia, 2013–2014 , 2015, Emerging infectious diseases.
[4] G. Yancopoulos,et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection , 2015, Proceedings of the National Academy of Sciences.
[5] Mohammed F. Yusof,et al. Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates , 2015, Virus Genes.
[6] R. Couch,et al. Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease , 2015, Journal of Virology.
[7] F. Berthe,et al. Human–Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection , 2014, Zoonoses and public health.
[8] V. Brown,et al. Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels , 2014, Emerging infectious diseases.
[9] D. Dimitrov,et al. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections , 2014, Microbes and Infection.
[10] Xinxia Peng,et al. Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset , 2014, PLoS pathogens.
[11] Jincun Zhao,et al. Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection , 2014, Journal of Virology.
[12] Jayaram K. Udupa,et al. A Generic Approach to Pathological Lung Segmentation , 2014, IEEE Transactions on Medical Imaging.
[13] Jincun Zhao,et al. T cell-mediated immune response to respiratory coronaviruses , 2014, Immunologic Research.
[14] K. Yuen,et al. Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein , 2014, Science Translational Medicine.
[15] R. Baric,et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution , 2014, Proceedings of the National Academy of Sciences.
[16] R. Baric,et al. Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.
[17] X. Qiu,et al. Antibody therapy for Ebola , 2014, Human vaccines & immunotherapeutics.
[18] Honglin Chen,et al. An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus , 2013, The Journal of infectious diseases.
[19] Michael G. Katze,et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques , 2013, Proceedings of the National Academy of Sciences.
[20] Ulas Bagci,et al. Spatially Constrained Random Walk Approach for Accurate Estimation of Airway Wall Surfaces , 2013, MICCAI.
[21] Christian Drosten,et al. Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.
[22] H. Feldmann,et al. Pneumonia from human coronavirus in a macaque model. , 2013, The New England journal of medicine.
[23] Christian Drosten,et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.
[24] O. Bohorov,et al. Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model , 2013, mAbs.
[25] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.
[26] R. Pebody,et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[27] T. Bestebroer,et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[28] E. Wald,et al. A review of palivizumab and emerging therapies for respiratory syncytial virus , 2011, Expert opinion on biological therapy.
[29] C. Broder,et al. A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection , 2009, PLoS pathogens.
[30] G. Stiegler,et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. , 2008, Plant biotechnology journal.
[31] W. Marasco,et al. The growth and potential of human antiviral monoclonal antibody therapeutics , 2007, Nature Biotechnology.
[32] Carola Engler,et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.
[33] Paul W. H. I. Parren,et al. Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41 , 2001, Journal of Virology.
[34] G. Shopp,et al. Bronchoalveolar Lavage Cytology in Cynomolgus Monkeys and Identification of Cytologic Alterations Following Sequential Saline Lavage , 1989, Veterinary pathology.
[35] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[36] S. V. Von Essen,et al. Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. , 1991, The American review of respiratory disease.
[37] V. Georgiev. Virology , 1955, Nature.